# Automated Process for Monitoring of Amiodarone Treatment: Development and Evaluation

## TL;DR

This paper presents a software robot that automates monitoring for patients on amiodarone, reducing lab tests and improving side effect detection.

## Contribution

A novel robotic process automation system for amiodarone follow-up, validated against physician decisions.

## Key findings

- The robot recommended longer follow-up intervals (4.5 months) compared to physicians (3.1 months).
- The robot detected all 12 new side effects, while physicians only identified 8.
- For normal lab results, the robot suggested 6-month intervals in 72.1% of cases, versus 9.7% by physicians.

## Abstract

Amiodarone treatment requires repeated laboratory evaluations of thyroid and liver function due to potential side effects. Robotic process automation uses software robots to automate repetitive and routine tasks, and their use may be extended to clinical settings.

Thus, this study aimed to develop a robot using a diagnostic classification algorithm to automate repetitive laboratory evaluations for amiodarone follow-up.

We designed a robot and clinical decision support system based on expert clinical advice and current best practices in thyroid and liver disease management. The robot provided recommendations on the time interval to follow-up laboratory testing and management suggestions, while the final decision rested with a physician, acting as a human-in-the-loop. The performance of the robot was compared to the existing real-world manual follow-up routine for amiodarone treatment.

Following iterative technical improvements, a robot prototype was validated against physician orders (n=390 paired orders). The robot recommended a mean follow-up time interval of 4.5 (SD 2.4) months compared to the 3.1 (SD 1.4) months ordered by physicians (P<.001). For normal laboratory values, the robot recommended a 6-month follow-up in 281 (72.1%) of cases, whereas physicians did so in only 38 (9.7%) of cases, favoring a 3- to 4-month follow-up (n=227, 58.2%). All patients diagnosed with new side effects (n=12) were correctly detected by the robot, whereas only 8 were by the physician.

An automated process, using a software robot and a diagnostic classification algorithm, is a technically and medically reliable alternative for amiodarone follow-up. It may reduce manual labor, decrease the frequency of laboratory testing, and improve the detection of side effects, thereby reducing costs and enhancing patient value.